Dey launches EpiPen app

Share this article:
Dey launches EpiPen app
Dey launches EpiPen app
Mylan's Dey Pharma launched MyEpiPen App, designed to help patients with severe allergies and their caregivers cope with episodes of anaphylaxis.

The app, available for free download to iPhone, iPod Touch and iPad, allow patients and their caregivers to create and share profiles about severe allergies for sharing with friends, family members, teachers, school nurses, camp counselors, daycare providers and babysitters.

Features also include a how-to video for the EpiPen Auto-injector and a user guide slideshow to help users visualize the three-step injection process.

The app may be used without entering any information that identifies a user, the company said, and information that is recorded is stored only on the user's mobile device.

Around 12 million Americans, or 4%, have a food allergy that may put them at risk of anaphylaxis, said the company. Anaphylaxis, a potentially life-threatening allergic reaction, can also be triggered by insect stings, medications, latex or other allergens. Dey's EpiPen buys sufferers some time to seek medical attention.
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.